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Population-based outcomes of open descending
thoracic aortic aneurysm repair
Marc L. Schermerhorn, MD, Kristina A. Giles, MD, Allen D. Hamdan, MD, Suzanne E. Dalhberg, PhD,
Robert Hagberg, MD, and Frank Pomposelli, MD, Boston, Mass
Objective: To evaluate national outcomes after open repair of descending thoracic aortic aneurysm (DTA).
Methods: The DTA repairs were identified from the NIS database from 1988-2003 by ICD9 codes for thoracic vascular
resection and replacement (38.45) and a diagnosis of intact (441.1) or ruptured (441.2) thoracic aortic aneurysm;
excluding thoraco-abdominal aneurysm, abdominal aortic aneurysm repair, cardioplegia, hypothermia, cardiac surgery,
or aorta to carotid or subclavian bypass. Demographics and comorbidities were noted. Outcomes included in-hospital
mortality, length of stay, and complications. Annual hospital surgical volume terciles (high, medium, and low) were
quantified for the series and patients assigned accordingly. Outcomes were compared between intact and ruptured
aneurysm characteristics as well as annual hospital volume. Predictors of peri-operative mortality were analyzed by
multivariate logistic regression.
Results: A total of 2549 DTA repairs were identified (1976 intact, 573 ruptured). Mortality was 18% overall; 10% for
intact (age <65 6.2%, 65-74 11.3%, >75 17.6%, P < .001), 45% for ruptured (age <65 33.3%, 65-74 47.1%, >75 52.4%,
P < .001). Mortality decreased over the 15-year time-period (P < .0001). Mortality after intact repair was lower at a high
volume hospital (HVH) (8%) than a low volume hospital (LVH) (13%) or medium volume hospital (MVH) (12%).
Hospital volume tercile did not predict rupture mortality. Complications after intact DTA repair were coded in 42%;
including respiratory (13%), cardiac (11%), acute renal failure (8%), stroke (3%), and neurologic (non-stroke) (2%).
Complications were coded in 49% after ruptured DTA repair including respiratory (13%), cardiac (13%), acute renal
failure (20%), stroke (3%), and neuro (non-stroke) (2%). Predictors of mortality (for all DTA repairs) were (odd ratio
[OR], 95% confidence interval [CI]): age 65-74 vs age <65 (1.8, 1.4-2.4), age >75 vs age <65 (2.7, 2.0-3.6), rupture
(6.3, 5.1-7.9), and LVH or MVH vs HVH (1.3, 1.1-1.7).
Conclusion: Mortality after open repair of DTA is high and complications are common. Mortality is dependent upon age,
rupture status, and hospital surgical volume. Results of endovascular DTA repair should be compared using similar
population-based data. ( J Vasc Surg 2008;48:821-7.)The incidence of thoracic aortic aneurysms has in-
creased significantly over the past 50 years.1-3 The rupture
risk approaches 50% in large descending thoracic aortic
aneurysms (DTA), therefore, early recognition and repair is
crucial to patient survival.4 Operative intervention however
is not without significant morbidity and mortality. Mortal-
ity rates for open surgical DTA repair have been reported at
3-12%.5-11 Most reports, however, are from high volume
centers of excellence and, therefore, these results may not
reflect the actual experience nationwide. Additionally,
many reports in the literature include the more extensive
thoraco-abdominal aortic aneurysms making it difficult to
ascertain the expected outcome after isolated DTA.11-15
With the recent Food & Drug Administration (FDA) ap-
proval of thoracic endovascular aneurysm repair (TEVAR) for
repair of DTA, it is important to have benchmarks for results
of open DTA repair and be able to compare population-based
outcomes. In this report, w e identify patients with isolated
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reflective of the national experience from the 16-year pe-
riod prior to FDA approval of TEVAR. We also examine
the effect of hospital surgical volume on mortality.
METHODS
Database. The Nationwide In-patient Sample is a da-
tabase maintained through the Healthcare Cost and Utili-
zation Project (HCUP) and represents an approximate 20%
random sample of all in-patient hospitalizations from 37
states. More than 8 million hospitalizations are represented
per year and the data recorded have been used extensively in
medical research to provide outcome analyses in a variety of
healthcare topics.16 In using this database for evaluation of
DTA repairs, we are able to study the population-based out-
comes and characteristics of this relatively rare procedure.
Patients. Clinical data were extracted from the Na-
tionwide Inpatient Sample (NIS) database from 1988-
2003 using diagnosis and procedure codes from the Inter-
national Classification of Diseases, 9th Revision, Clinical
Modification (ICD-9-CM) system codes. A procedure code
for thoracic vascular resection and replacement (38.45) and a
diagnosis of thoracic aortic aneurysm (441.1 or 441.2) iden-
tified patients who had undergone repair of a thoracic aortic
aneurysm within the admission. To isolate descending tho-
racic aneurysms, exclusion criteria included concomitant
diagnosis of thoraco-abdominal aneurysm (441.6, 441.7),
821
JOURNAL OF VASCULAR SURGERY
October 2008822 Schermerhorn et alabdominal aortic aneurysm repair (38.44), cardioplegia
(39.63), hypothermia (39.62), cardiac surgery (35.00-
37.99), aorta to carotid or subclavian bypass (39.22), and
intrathoracic bypass (39.23). In addition, patients were
required to be 18 years of age or older to minimize inclu-
sion of congenital anomalies.
Demographics and hospital volume. Each patient
was classified as having either an intact (441.2) or a rup-
tured (441.1) aneurysm based upon their qualifying ICD-9
diagnosis code. In addition, hospital-specific surgical vol-
umes were tabulated for each year within the dataset and
terciles of operative volume were defined as a low volume
hospital (LVH), a medium volume hospital (MVH), and a
high volume hospital (HVH). Each patient within the
sample was then assigned into one of these categories based
on their designated institution and hospitalization year.
Age, gender, race, and comorbidities were docu-
mented. Comorbid conditions were determined by ICD-9
diagnosis codes. These included coronary artery disease
(CAD), prior myocardial infarction, congestive heart failure
(CHF), chronic obstructive pulmonary disease (COPD),
chronic renal failure (CRF), cerebral vascular disease
(CVD), diabetes mellitus (DM), hypertension, and periph-
eral vascular disease (PVD).
Outcomes. The primary outcome variable was in-hospital
mortality and secondary outcomes included total length of stay
(LOS) and complications. Complications were identified by
ICD-9 codes for complications of surgical and medical care
(996-999) and included stroke, non-stroke neurologic,
cardiac, and respiratory complications. Coding for acute
renal failure was also considered a complication diagnosis.
Outcomes were compared between intact and ruptured
groups as well as among hospital surgical volume terciles.
Statistical analysis. The NIS database querying was
done using SAS 9.1 statistical software (SAS Institute Inc,
Cary, NC). All statistical analysis was then performed with
R statistical software (R Foundation for Statistical Comput-
ing, Vienna, Austria). Characteristics and outcomes were
compared by Pearson’s 2 and Kruskal-Wallis tests for
categorical and continuous variables, respectively. Mortal-
ity over time was analyzed by the 2 test of trend as well as
logistic regression. Overall predictors of mortality were
then analyzed by univariate andmultivariate logistic regres-
sion. Due to the inability to determine whether some
coexisting diagnoses were complications versus preexisting
comorbidities, separate multivariate models were derived
with and without comorbidities to ensure the reliability of
the results. Statistical significance was defined as P  .05.
RESULTS
Overall demographics. A total of 2549 DTA repairs
were identified from the database within the years 1988-
2003. There were 1976 (77.5%) intact and 573 (22.5%)
ruptured aneurysms. Overall demographic and comorbid-
ity characteristics are shown in Table I. The median age was
68 years with a prevalence of White males. Approximately
half of the sample was diagnosed with hypertension and
17% hadCADwhile other comorbidities were rare (10%).Outcomes. Overall, in-hospital mortality after surgery
was 18.3% (Table I). Mortality decreased over the 15-year
time-period with an average odds decrease of 0.94 per year
(Fig 1) (P  .0001). Mortality rates varied significantly by
patient age with those 75 years having a 20% greater
mortality than those 65 years. Complications included
Table I. Demographic characteristics and peri-operative
mortality of patients undergoing open repair of
descending thoracic aneurysms
Age (median, range) 68 (18, 93)
Male (%) 57.6
White race (%)* 81.7
Ruptured TAA (%) 22.5
Comorbidity (%)
Hypertension 48.2
Coronary artery disease 17.3
Prior myocardial infarction 3.0
Congestive heart failure 8.2
Chronic obstructive pulmonary disease 5.5
Chronic renal failure 1.8
Cerebrovascular disease 5.0
Diabetes, without complications 5.5
Diabetes, with complications 0.47
Peripheral vascular disease 1.6
% Mortality
Overall 18.3
Patient age
65 years 10.6
65-74 years 19.0
75 years 29.6
Ruptured TAA 45.2
Intact TAA 10.4
TAA, Thoracic aortic aneurysm.
*830 missing values.
Fig 1. Mortality after repair of descending thoracic aortic aneu-
rysm by year of repair.respiratory (13.3%), cardiac (11.6%), acute renal failure
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cations (1.5%). Median length of stay was 17 days (range,
1-330) for all patients.
Intact vs ruptured DTA. Patients with ruptured aneu-
rysms were significantly older than those with intact aneu-
rysms (Table II). Gender and race were equivalent between
the two groups. There were a significantly greater proportion
of patients with a diagnosis of CAD and hypertension in the
intact aneurysm group while the ruptured group was more
frequently diagnosedwithCHFandCRF.All other comorbid
conditions were similar between the groups.
Mortality was 10.4% for intact and 45.2% for ruptured
DTA (Table III). Mortality increased significantly with age
for both intact and ruptured DTA.Median LOSwas longer
after intact repair. The LOS among those who died was
longer than the LOS in those surviving for intact aneurysms
(23 vs 17 days) but shorter for ruptured aneurysms (4 vs 21
days). Global complications and acute renal failure were
more frequent after ruptured DTA repair than intact repair.
Hospital volume. Results of analysis by hospital vol-
ume are presented in Tables IV and V. The lowest volume
tercile was characterized by the performance of only one
DTA repair annually while MVHs performed a median of 2
procedures (range, 2-3) and HVHs performed a median of
4 (range, 3-25). The total number of procedures per-
formed within the LVH group was 685 (27%), however the
LVHs accounted for 55% of the hospitals represented.
Table II. Demographic data of patients undergoing
open repair of descending thoracic aneurysms for intact
versus ruptured aneurysms
Intact
n  1976
Ruptured
n  573 P-value
Age (median, range) 67 (18, 92) 72 (20, 93) .001
65 years 54 (18-64) 53 (20-64) .90
65-74 years 70 (65-74) 71 (65-74) .001
75 years 77 (75-92) 79 (75-93) .001
Male (%) 57.2 58.8 .53
White race (%)* 81.6 81.9 .96
Comorbidity (%)
Hypertension 51.1 38.4 .001
Coronary artery disease 18.7 12.2 .001
Prior myocardial
infarction 3.1 2.8 .88
Congestive heart
failure 7.2 11.5 .01
Chronic obstructive
pulmonary disease 5.6 4.9 .57
Chronic renal failure 1.4 3.3 .01
Cerebrovascular disease 4.7 6.1 .19
Diabetes, without
complications 5.7 5.1 .65
Diabetes, with
complications 0.5 0.4 .89
Peripheral vascular
disease 1.5 1.9 .57
Missing values are excluded from the denominator in the tabulation of the
rate.
*830 missing values.Conversely, 1262 procedures were performed at high vol-ume centers which represented 21% of the hospitals iden-
tified (Fig 2).
There was a similar age, gender, race, and comorbidity
distribution across the hospital volume terciles. The per-
centage of ruptured DTA repairs was significantly higher in
low and medium volume institutions versus high volume
institutions.
Overall, mortality was significantly higher within low
and medium volume centers versus high volume centers
(Table V, Fig 3). Mortality after intact repair was lowest at
HVH (8%) versus LVH (13%) or MVH (12%). Mortality
after elective repair was not improved further with a higher
volume cutoff (Fig 3). Hospital volume terciles did not
demonstrate differences for rupture mortality.
Median LOS increased as hospital volume increased.
There were no significant differences in complication rates
among the volume groups.
Multivariate analysis. Independent predictors of mor-
tality were age, rupture, and hospital volume (Table VI).
When including comorbidities, CVD, CRF, and absence
of hypertension were additional predictors of mortality
(Table VII).
DISCUSSION
In-hospital mortality associated with open repair of
DTAs is high but varies significantly by hospital operative
volume. Even in high volume hospitals, peri-operativemor-
tality with repair of intact DTA was 8%. Ruptured aneu-
rysms carried approximately a 45% mortality rate regardless
of hospital experience. Peri-operative mortality for intact
and ruptured DTA decreased over the time period of the
study.
Morbidity is also very high for open DTA repair with
complication rates reaching 50%. Differences in hospital
volume did not significantly affect morbidity rates.
In the past, mortality rates of 3-12% have been reported
for descending thoracic aneurysms.5-11 Most prior publica-
Table III. Peri-operative mortality and outcomes of
patients undergoing open repair of descending thoracic
aneurysms for intact versus ruptured aneurysms
Intact
n  1976
Ruptured
n  573 P-value
Mortality (%) 10.4 45.2 .001
Patient age (% mortality)
65 years 6.2 33.3 .001
65-74 years 11.3 47.1 .001
75 years 17.6 52.4 .001
LOS (median, range) 18 (1, 330) 15 (1, 110) .001
Complications (%)
Global 42.3 48.5 .01
Stroke 2.6 3.3 .46
Neuro non-stroke 1.5 1.7 .78
Cardiac 11.2 12.7 .36
Respiratory 13.4 13.1 .90
Acute renal failure 7.7 20.0 .001
LOS, Length of stay.tions have been reports from academic centers of excel-
rate.
volu
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comes are likely to be better in these studies than in an
overall population-based study such as performed here.
The 10% intact DTA mortality and 45% ruptured DTA
mortality based on a national sample is likely representative
of the true population risk over the time course reported.
A large study by Svensson et al5 reported 832 cases of
open DTA repair performed from 1956-1991. The series
was comprised of only 30% females and the median age was
younger (65 years) than that in this series. Additionally,
indications other than aneurysmal disease such as trauma and
Table IV. Hospital volume characteristics and demograph
descending thoracic aneurysms by hospital volume strata
LVH
Hospital Characteristics
Total number of procedures 685 (26.9%)
Number of hospitals within category 685
Median number of procedures 1
Range (1, 1)
Patient Characteristics
Age (median, range) 68 (21, 89)
Male (%) 56.9
White race (%)* 83.9
Ruptured TAA (%) 25.4
Comorbidity (%)
Hypertension 47.2
Coronary artery disease 17.4
Prior myocardial infarction 2.2
Congestive heart failure 7.0
Chronic obstructive pulmonary disease 6.1
Chronic renal failure 1.9
Cerebrovascular disease 5.3
Diabetes, without complications 6.9
Diabetes, with complications 0.6
Peripheral vascular disease 2.5
LVH, Low volume hospital; MVH, medium volume hospital; HVH, high v
Missing values are excluded from the denominator in the tabulation of the
*830 missing values.
Table V. Peri-operative mortality and outcomes of patien
by hospital volume strata
LVH
Mortality (%) 21.7
Patient age (% mortality)
65 years 12.0
65-74 years 22.1
75 years 34.7
Ruptured DTA (% mortality) 46.5
Intact DTA (% mortality) 13.2
LOS (median, range) 15 (1, 176)
Complications (%)
Global complications 44.4
Stroke 2.3
Neuro non-stroke 2.2
Cardiac 11.2
Respiratory 12.4
Acute renal failure 10.8
DTA, Descending thoracic aortic aneurysms; LOS, length of stay; LVH, lowdissectionwere included. The 30-daymortality was 8% overall(21% for ruptured pathology and 7% for non-ruptured).
Complications reported included 7% acute renal failure, 5%
paraparesis, 2.3% paraplegia, 3% stroke, 10% cardiac com-
plications, and 28% pulmonary complications.
More recently, the reported literature has focused upon
comparing endovascular stent grafts for repair versus the
traditional open technique. These reports include single
institutional experiences as well as twomulticenter compar-
ative trials. One such institutional study by Stone et al6
reported an open cohort of 93 patients from 1996-2005.
Peri-operative mortality was 15.1% overall and 9.6% for
aracteristics of patients undergoing open repair of
MVH HVH P-value
602 (23.6%) 1262 (49.5%)
297 265
2 4
(2, 3) (3, 25)
68 (18, 93) 68 (18, 92) .15
57.8 57.8 .94
78.9 81.8 .18
24.9 19.7 .01
47.8 49.0 .73
14.3 18.6 .07
2.2 3.9 .05
8.1 8.8 .39
5.8 4.9 .48
1.7 1.8 .95
5.3 4.7 .78
6.1 4.5 .07
0.5 0.4 .84
1.8 1.0 .05
hospital; TAA, thoracic aortic aneurysm.
dergoing open repair of descending thoracic aneurysms
MVH HVH P-value
20.4 15.5 .01
11.1 9.7 .60
20.2 16.6 .17
36.4 23.6 .01
45.6 44.2 .89
12.0 8.4 .01
17 (1, 98) 19 (1, 330) .01
41.0 44.5 .33
2.5 3.2 .50
1.3 1.3 .26
8.6 13.2 .05
13.3 13.9 .66
11.3 9.8 .58
me hospital; MVH, medium volume hospital; HVH, high volume hospital.ic ch
olumets unintact DTA repairs. Mean age was 71 years and length of
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paresis, 4.5% paraplegia, and 8% intra-operative stroke.
Multicenter trials include those published byBavaria et al7
and Matsumura et al.11 The former had an open cohort of
94 patients and a peri-operative mortality of 11.7% while
the latter had an open cohort of 70 patients and a peri-
operative mortality of 5.7%. Complications reported by
Bavaria et al included 20% respiratory, 13% renal, 1% myo-
cardial infarction, 4% CVA, and paraplegia/paraparesis of
14%. Matsumura et al reported complication rates of 44%
pulmonary, 14% renal, 44% cardiac, 8.5% CVA, and 6%
Fig 2. Distribution of annual hospital surgical volume.
Fig 3. Mortality by annual hospital surgical volume.paraplegia.Mortality, age, and length of stay in these recent trials are
similar to the current studywith the exception of themortality
of 5.7% reported byMatsumura et al.11 The neurologic com-
plication rates for the most part show a substantial difference
and likely represent under-coding of post-operative complica-
tions relating to neurologic deficits, whether from spinal cord
injury or stroke. Interestingly, we report cardiac and renal
complications at 12% and 10% which may be more accurately
coded as they are somewhat closer to rates reported in series
reporting these outcomes.5,7,11
The second aimof our studywas to evaluate differences in
outcome based on ruptured pathology. Our findings of a 45%
mortality associated with rupture is significantly greater than
the study by Svensson et al.5 This series represented an annual
surgical volume greater than any center noted in our study
and, therefore, may reflect a unique expertise with the proce-
dure as well as specifics regarding referral practices in their
location. We also cannot make conclusions regarding hemo-
dynamic status of those chosen for transfer and who survive
transfer.
There are a few population studies assessing outcomes
of thoraco-abdominal aneurysm repairs. Cowan et al17
reported NIS data from 1988 to 1998 on intact thoraco-
abdominal aneurysm repair and found significant mortality
differences between low and high volume hospitals as well
as high and low volume surgeons. They also studied rup-
tured thoraco-abdominal aneurysms and, as we have, found
Table VI. Multivariate predictors of mortality associated
with descending thoracic aortic aneurysm repair, with
comorbidities included
OR 95% CI P-value
Age 65-74 vs Age 65 1.8 1.4-2.4 .001
Age 75 vs Age 65 2.6 2.0-3.5 .001
Comorbidities
Chronic renal failure 3.0 1.5-6.0 .01
Cerebrovascular disease 2.8 1.9-4.3 .001
Hypertension 0.7 0.6-0.9 .05
LVH/MVH vs HVH 1.3 1.1-1.6 .05
Ruptured vs Intact TAA 6.1 4.9-7.7 .001
LVH, Low volume hospital; MVH, medium volume hospital; HVH, high
volume hospital; TAA, thoracic aortic aneurysm.
Table VII. Multivariate predictors of mortality
associated with descending thoracic aortic aneurysm
repair, with comorbidities excluded
OR 95% CI P-value
Age 65-74 vs Age 65 1.8 1.4-2.4 .001
Age 75 vs Age 65 2.7 2.0-3.6 .001
LVH/MVH vs HVH 1.3 1.1-1.7 .01
Ruptured vs Intact TAA 6.3 5.1-7.9 .001
OR, Odd ratio; CI, confidence interval; LVH, low volume hospital; MVH,
medium volume hospital;HVH, high volume hospital; TAA, thoracic aortic
aneurysm.no relationship of volume to outcome.18 As expected,
JOURNAL OF VASCULAR SURGERY
October 2008826 Schermerhorn et almortality after intact DTA repair in our study (10%) was
lower than mortality after intact thoraco-abdominal aortic
aneurysm repair (15%) in Cowan’s study. Derrow et al19
previously reported a 20% mortality after elective thoraco-
abdominal aneurysm repair in the NIS from 1993 to 1997.
The complication rate was high at 62% versus our finding of
a 42% global complication rate. Rigberg et al20 used a
California statewide database and assessed 30-day mortality
in 1010 patients from 1991 to 2002. Mortality was 19% for
intact and 48.4% for ruptured thoraco-abdominal aneu-
rysm repair. They found no relationship of procedural
volume to mortality outcome. Compared to our current
study, this database had an older median age for elective
repair (70 years vs 67 years) and a greater percentage of
male patients (62% intact and 68% ruptured vs 57% intact
and 59% ruptured).
In comparison to outcomes reported for open repair of
thoracic aneurysms, endovascular repair for thoracic aneu-
rysms shows promising results for substantial mortality
benefits. The European Collaborators on Stent Graft Tech-
niques for Thoracic Aortic Aneurysm andDissection Repair
(EUROSTAR) and the United Kingdom Thoracic En-
dograft registries reported a 30-day mortality of 5.3% for
elective repair and 25% for emergent repair.21 Population-
based studies as this technique gains widespread use will be
important for future direct comparisons.
There are important limitations that are inherent to
studies using administrative data sets. There could be con-
siderable coding variability among institutions limiting the
ability to accurately identify comorbid conditions, compli-
cations, and even confusing the primary diagnoses and
procedures. The standardization of the ICD-9 coding sys-
tem helps to minimize this, however, the dataset only
represents what is recorded in discharge information. Be-
cause one cannot reliably determine, using this dataset,
whether some comorbid conditions were in fact pre-existing
or were complications, separate multivariate models were run
with and without comorbidities to control for this limitation.
While CRF and CVD predicted worse outcome, these may
have been indicative of postoperative stroke or dialysis re-
quirements. In the model excluding comorbidities, how-
ever, there was little impact on the other predictors of
adverse outcome (age, rupture, emergency admission, and
hospital volume) strengthening the independence of these
findings. Additionally, due to limitations in the ICD-9
coding system captured by the NIS, we chose to exclude
patients undergoing DTA repair using circulatory arrest.
While some surgeons use circulatory arrest for routine DTA
repair, it is more commonly used for more extensive aortic
arch surgery. The exclusion was necessary to more accu-
rately select for DTA repairs only.
This study demonstrates that DTA repair across the US
is associated with a highmortality andmorbidity. For intact
DTA, outcomes are superior at more experienced centers
while this was not seen for ruptured DTA. This study
includes the period prior to the introduction of TEVAR
and should serve as a benchmark for trials of TEVAR.
Analysis of TEVAR outcomes should include population-based studies when these data are available to be sure that
efficacy demonstrated in high volume centers of excellence
can be generalized to the US population.
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